1.
J Allergy Clin Immunol
; 139(5): 1423-1430, 2017 May.
Article
in English
| MEDLINE
| ID: mdl-28477721
ABSTRACT
Biologic agents are important therapeutic options for treating multiple moderate-to-severe cutaneous diseases. Monoclonal antibodies already in use or under investigation are targeted for psoriasis, atopic dermatitis, melanoma, hidradenitis suppurativa, and pemphigus vulgaris.
